Severe gout is a disease with high prevalence and often confronts physicians, reumatologists but also emergency physicians.

DREAM-gout was initiated by dr. Tim Jansen (Viecuri). DREAM started monitoring gout care and outcomes in August 2017. We hope to establish what role uricosuric agents play in the treatment of severe gout and which outcomes are the most important to patients. This will clarify what can be improved in the treatment of severe gout. 

Currently, approximately 140 gout patients are included in the registry

Cumulative inclusion in DREAM-Gout

DREAM team

The DREAM-Gout team consists of:

  • VieCuri (Venlo): dr. Tim Jansen
  • Medisch Spectrum Twente (Enschede): dr. Harald Vonkeman
  • Maastricht University Medical Center: dr. Astrid van Tubergen